Exploring Genetic Silencing: RNAi and CRISPR-Cas Potential against Drug Resistance in MalariaMINI-REVIEWS IN MEDICINAL CHEMISTRYIF3.32025-02-010PRE
Advances in the Development of Carbonic Anhydrase Inhibitors as New Antiprotozoal AgentsCURRENT MEDICINAL CHEMISTRYIF3.52024-12-010PRE
Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential DrugsPHARMACEUTICALSIF4.82023-04-042OAAI